Caregiver Distress clinical trials

Explore recruiting caregiver distress clinical trials.

Recruiting caregiver distress studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Caregiver Distress trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants with Alzheimer’s Disease Dementia

Italy, Slovakia, Spain, Poland, Czechia, Germany

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-2)

Poland, Greece, Belgium, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

France, Czechia, Slovakia, Hungary, Portugal, Romania +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

MEDICAL CANNABIS FOR NEURODEGENERATIVE DISEASES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL (NEUROBIS)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Caregiver Distress trials by city

Caregiver Distress in Toronto Caregiver Distress in Vancouver Caregiver Distress in Montreal Caregiver Distress in Calgary Caregiver Distress in Edmonton Caregiver Distress in Ottawa Caregiver Distress in Winnipeg Caregiver Distress in Quebec City Caregiver Distress in Hamilton Caregiver Distress in Kitchener Caregiver Distress in London Caregiver Distress in Halifax Caregiver Distress in New York Caregiver Distress in Los Angeles Caregiver Distress in Chicago Caregiver Distress in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease